<DOC>
	<DOCNO>NCT01399736</DOCNO>
	<brief_summary>The Compare-Acute trial prospective randomise trial patient multivessel disease , admit hospital ST-elevation Myocardial Infarction . The purpose study compare FFR guide multivessel PCI take place primary PCI primary PCI culprit vessel . Patients enrol successful revascularisation culprit vessel . Patients least one lesion diameter stenosis 50 % visual estimation , feasible ( operator judgement ) treatment PCI non-infarct related artery , randomise either FFR guide complete revascularisation arm stag revascularisation proven ischemia persistence symptom angina . Approximately 885 patient enter study . Study hypothesis : FFR-guided complete percutaneous revascularisation flow-limiting stenosis non-IRA perform within procedure primary PCI within hospitalisation improve clinical outcome compare staged revascularisation , guide prove ischemia clinical judgment , recommend guideline .</brief_summary>
	<brief_title>Comparison Between FFR Guided Revascularization Versus Conventional Strategy Acute STEMI Patients With MVD .</brief_title>
	<detailed_description>Background study : At moment general opinion divide way non culprit lesion patient present STEMI treat . While previous guideline stead lesion treat second time ( ie primary intervention ) actual guideline touch argument . The reason study previous guideline base old . Meanwhile small size randomised trial EU region proven favourable outcome NON infarct relate artery primary procedure register ( non randomise trial ) USA still recommend staged treatment . For reason decide perform randomise study address issue incorporate state art diagnosis treatment , well new medical therapy PCI technique . Objective study : FFR-guided complete percutaneous revascularisation flow-limiting stenosis non-IRA perform within procedure primary PCI within hospitalisation improve clinical outcome compare staged revascularisation , guide prove ischemia clinical judgment , recommend guideline Study design : Prospective , 1 : 2 randomisation . FFR guide revascularisation primary PCI ( 1 ) versus follow actual guideline ( 2 ) Study population : All STEMI patient 18-85 year treat primary PCI &lt; 12 h ( 12 hr persist pain allow ) onset symptom least one stenosis &gt; 50 % non-IRA judged feasible treatment PCI . Intervention ( applicable ) : FFR-guided complete percutaneous revascularisation flow-limiting stenosis non-IRA perform within procedure primary PCI within hospitalisation improve clinical outcome compare staged revascularisation , guide prove ischemia clinical judgment , recommend guideline Primary study parameters/outcome study : Composite endpoint cause mortality non-fatal Myocardial Infarction , Revascularisation Stroke ( MACCE ) 12 month</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>All patient 1885 year present STEMI treat primary PCI &lt; 12 h onset symptoms* least one stenosis &gt; 50 % nonIRA QCA visual estimation baseline angiography judge feasible treatment PCI operator . Patients symptoms 12 hr ongoing angina complaint randomise 1 . Left main stem disease ( stenosis &gt; 50 % ) 2 . STEMI due instent thrombosis 3 . Chronic total occlusion nonIRA 4 . Severe stenosis TIMI flow â‰¤ II nonIRA artery . 5 . NonIRA stenosis amenable PCI treatment ( operator decision ) 6 . Complicated IRA treatment , one following ; Extravasation , Permanent reflow IRA treatment ( TIMI flow 01 ) , Inability implant stent 7 . Known severe cardiac valve dysfunction require surgery followup period . 8 . Killip class III IV already presentation completion culprit lesion treatment . 9 . Life expectancy &lt; 2 year . 10 . Intolerance Aspirin , Clopidogrel , Plasugrel , Ticagrelor , Heparin , Bivaluridin , Everolimus know true anaphylaxis prior contrast medium bleed diathesis know coagulopathy . 11 . Gastrointestinal genitourinary bleeding within prior 3 month , 12 . Planned elective surgical procedure necessitate interruption thienopyridines first 6 month post enrolment . 13 . Patients actively participate another drug device investigational study , complete primary endpoint followup period . 14 . Pregnancy plan become pregnant time enrolment study . 15 . Inability obtain informed consent . 16 . Expected lose followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>PCI FFR STEMI MVD</keyword>
	<keyword>FFR guide PCI acute STEMI patient MVD</keyword>
</DOC>